CA
EMN icon

Capitolis Advisors’s Eastman Chemical EMN Stock Holding History

Capitolis Advisors’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-114,000
Closed -$13.8M – 255
2021
Q4 		$13.8M Hold
114,000
– – 0.08% 178
2021
Q3 		$12.2M Hold
114,000
– – 0.11% 148
2021
Q2 		$13.3M Buy
114,000
+105,141
+1,187% +$12.6M 0.16% 141
2021
Q1 		$976K Hold
8,859
– – 0.02% 309
2020
Q4 		$888K Buy
+8,859
New +$821K 0.01% 416

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Capitolis Advisors's EMN Position: Q1 2022 in Review

Capitolis Advisors sold out of Eastman Chemical (EMN) in Q1 2022, closing a stake of 114,000 shares — an estimated $13.8M sold.

Capitolis Advisors first reported a position in EMN in Q4 2020 and held it in 5 quarters. The position peaked at $13.8M in Q4 2021. 751 funds tracked by Wall St. Rank hold EMN as of Q1 2022.

  • Capitolis Advisors reported no remaining Eastman Chemical position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 114,000 Eastman Chemical shares in Q1 2022, an estimated $13.8M.
  • Capitolis Advisors first reported a position in Eastman Chemical in Q4 2020 and held it in 5 quarters.
  • Capitolis Advisors's Eastman Chemical position peaked at $13.8M in Q4 2021.
  • 751 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.